Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Carl Barrett

Showing results (81-90 of 224) with videos related to

Pageof 23
Sort By:
BMC Cancer|January 4, 2022
Landscape of homologous recombination deficiencies in solid tumours: analyses of two independent genomic datasetsZhongwu Lai, Matthew Brosnan, Ethan S Sokol, et al.
Clinical Chemistry|February 25, 2020
Development, Validation, and Regulatory Considerations for a Liquid Biopsy TestDana W Y Tsui, Gideon M Blumenthal, Reena Philip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancerG Larry Maxwell, G V R Chandramouli, Lou Dainty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2014
Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter SystemMargaret H Veldman-Jones, Zhongwu Lai, Mark Wappett, et al.
Toxicologic Pathology|June 19, 2004
Tumor spectrum in the p53 heterozygous zeta globin-promoted Tg.AC (v-Ha-ras) bitransgenic mouse modelKeith R Martin, Michael P Jokinen, Hayden P Honeycutt, et al.
Journal for Immunotherapy of Cancer|July 20, 2024
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers CommitteeAnne Monette, Sarah Warren, J Carl Barrett, et al.
JCO Precision Oncology|October 30, 2025
Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of TreatmentAleksandra Markovets, Diana Merino Vega, Chris Abbosh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serumDavid Berrigan, Nancy Potischman, Kevin W Dodd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancerNomelí P Núñez, Danijela Jelovac, Luciana Macedo, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 16, 2004
Tumor profile of novel p53 heterozygous Tg.AC (v-Ha-ras) bitransgenic mice treated with benzo(a)pyrene and fed dietary N-acetyl-L-cysteine (NAC)Keith R Martin, Micheal P Jokinen, Hayden P Honeycutt, et al.
Pageof 23

Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
BMC Cancer|January 4, 2022
Landscape of homologous recombination deficiencies in solid tumours: analyses of two independent genomic datasetsZhongwu Lai, Matthew Brosnan, Ethan S Sokol, et al.
Clinical Chemistry|February 25, 2020
Development, Validation, and Regulatory Considerations for a Liquid Biopsy TestDana W Y Tsui, Gideon M Blumenthal, Reena Philip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancerG Larry Maxwell, G V R Chandramouli, Lou Dainty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2014
Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter SystemMargaret H Veldman-Jones, Zhongwu Lai, Mark Wappett, et al.
Toxicologic Pathology|June 19, 2004
Tumor spectrum in the p53 heterozygous zeta globin-promoted Tg.AC (v-Ha-ras) bitransgenic mouse modelKeith R Martin, Michael P Jokinen, Hayden P Honeycutt, et al.
Journal for Immunotherapy of Cancer|July 20, 2024
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers CommitteeAnne Monette, Sarah Warren, J Carl Barrett, et al.
JCO Precision Oncology|October 30, 2025
Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of TreatmentAleksandra Markovets, Diana Merino Vega, Chris Abbosh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serumDavid Berrigan, Nancy Potischman, Kevin W Dodd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancerNomelí P Núñez, Danijela Jelovac, Luciana Macedo, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 16, 2004
Tumor profile of novel p53 heterozygous Tg.AC (v-Ha-ras) bitransgenic mice treated with benzo(a)pyrene and fed dietary N-acetyl-L-cysteine (NAC)Keith R Martin, Micheal P Jokinen, Hayden P Honeycutt, et al.
Pageof 23